Skip to main content
European Radiology Experimental

Table 4 Kaplan–Meier survival curves for progression-free survival

From: Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional study

 

Mean by months

% End of study by months

Log-rank

χ2

p value

Groups

 Group A

23.0

66.7

2.622

0.105

 Group B

39.0

92.3

Back to article page